hyaluronoglucosaminidase has been researched along with Graves Ophthalmopathy in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gan, L; Li, Q; Ma, R; Qian, J; Wang, Z; Yuan, Y | 1 |
Cheng, Y; Gan, L; Ma, R; Qian, J; Ren, H; Wu, J; Xu, B; Zhang, R | 1 |
LAURENT, LP; SCOPES, JW | 1 |
OBERDISSE, K | 1 |
4 other study(ies) available for hyaluronoglucosaminidase and Graves Ophthalmopathy
Article | Year |
---|---|
Modulation of hyaluronan polymer size regulates proliferation of perimysial fibroblasts in thyroid eye disease.
Topics: Adult; Cell Adhesion Molecules; Cell Proliferation; Cells, Cultured; Female; Fibroblasts; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Insulin-Like Growth Factor I; Male; Middle Aged; Oculomotor Muscles; Particle Size; Structure-Activity Relationship | 2018 |
PH20 Inhibits TGFβ1-Induced Differentiation of Perimysial Orbital Fibroblasts via Hyaluronan-CD44 Pathway in Thyroid-Associated Ophthalmopathy.
Topics: Analysis of Variance; Case-Control Studies; Cell Differentiation; Cells, Cultured; Fibroblasts; Graves Ophthalmopathy; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Orbit; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1 | 2019 |
Hyaluronidase in the treatment of exophthalmic ophthalmoplegia.
Topics: Exophthalmos; Graves Ophthalmopathy; Humans; Hyaluronoglucosaminidase; Hyperthyroidism; Ophthalmoplegia | 1955 |
[Isotopes in diagnosis and treatment of endocrine exophthalmos].
Topics: Exophthalmos; Goiter; Graves Disease; Graves Ophthalmopathy; Humans; Hyaluronoglucosaminidase; Iodine Isotopes; Prednisone; Thiouracil; Thyrotropin | 1962 |